|
| |
cubicin patent Pages on BioPortfolio:
BioPortfolio - cubicin patent
cubicin patent - BioPortfolio. ... The FDA Orange Book listed patents for CUBICIN are U.S. Patent Nos. ...
http://www.bioportfolio.com/search/cubicin_patent.html...
|
Biotechnology News Cubist cdad. cubicin. ecallantid. gram. hcv ...
Current Search: cubist: 114, cdad: 10, cubicin: 46, ecallantid: 51, gram: 391, ... Title: United States Patent: 7427668 Inventors: Gorman; Daniel M. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
BioPortfolio - CUBICIN®
CUBICIN® - Entry on Bioportfolio's Biocorporate Database. ... Recent Search Terms used to find this page: cubicin patent | cubicin patent | cubicin patent
...
http://www.bioportfolio.com/biocorporate/21526-CUBICIN%25C2%...
|
sepracor issues earning, settles patent dispute
boston globe:
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...
|
BioPortfolio - www.cubicin.com
BioPortfolio - cubicin patent For full prescribing information, visit www. cubicin.com. U.S. Patent No. 6468967 provides U.S. market exclusivity for the
...
http://www.bioportfolio.com/search/www.cubicin.com.html...
|
BioPortfolio - arbelic 2008
BioPortfolio - arbelic 2008 BioPortfolio - cubicin patent On January 29, 2008, the U.S. Patent Office issued a certificate of. correction. ...
http://www.bioportfolio.com/search/arbelic_2008.html...
|
BioPortfolio - Cellulitis
US Patent No. Title. 7351720, N-ureidoalkyl-piperidines as modulators of ... CUBICIN® (daptomycin for injection), the only once-a-day agent approved for the
...
http://www.bioportfolio.com/indepth/Cellulitis.html...
|
Antibacterial hope lies in clever drugs for superbugs
In anticipation of Augmentin's patent expiry, GSK launched two follow-up ... Pfizer's Zyxox (linezolid) in 2000 and Cubist's Cubicin (daptomycin) in 2003,
...
http://www.bioportfolio.com/news/datamonitor_142.htm...
|
BioPortfolio - Ankle
US Patent No. Title. 7431696, Monitoring device, method and system ... CUBICIN® (daptomycin for injection), the only once-a-day agent approved for the ...
http://www.bioportfolio.com/indepth/Ankle.html...
|
BioPortfolio Limited Hospital Antibacterials A market beyond MRSA
Cubicin.... 249 Tygacil.... 250 Zeven.... 251 Arbelic.... 252 Finibax.... 253 Ceftobiprole.... 253 Iclaprim.... 254 Ceftaroline.... 255 Patent expiries: ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_795.html...
|
Results from other life science and pharmaceutical sites:
Dockets: 2006E-0042: Patent Extension Application for CUBICIN ...
2006E-0042: Patent Extension Application for CUBICIN (daptomycin for injection), ... U.S. Patent and Trademark Office, pdf. Signature: Karin Ferriter ...
http://www.fda.gov/ohrms/DOCKETS/DOCKETS/06e0042/06e0042.htm...
|
BioPortfolio - CUBICIN®
CUBICIN® - Entry on Bioportfolio's Biocorporate Database. ... Recent Search Terms used to find this page: cubicin patent | cubicin patent | cubicin patent
...
http://www.bioportfolio.com/biocorporate/21526-CUBICIN%25C2%...
|
CUBICIN Guide to IP Protection - March 2008.qxp
CUBICIN is protected by three patents which are included in the FDA Orange Book. The FDA Orange Book listed patents for CUBICIN are U.S. Patent Nos. ...
http://www.cubist.com/downloads/CUBICIN%20Guide%20to%20IP%20...
|
Drug Maker Targets Infections That Are Resistant To Antibiotics ...
And as Cubicin gains market share, it makes itself a more attractive target for generic drug makers. Cubicin has patent protection on the dosing and ...
http://biz.yahoo.com/ibd/081113/newamer.html?.v=1...
|
About / News / FDA Approves Expanded Label for IV Antibiotic CUBICIN®
25 May 2006 ... U.S. Patent No. 6468967 provides U.S. market exclusivity for the once-daily administration of CUBICIN until 2019. About CUBICIN® (daptomycin ...
http://www.cubist.com/about/news/27/fda_approves_expanded_la...
|
Cubicin® (daptomycin for injection) Rx only
US Patent Nos. 4874843; 4885243; 6468967; 6696412; 6852689; RE39,071. CUBICIN is a registered trademark of Cubist Pharmaceuticals, Inc. All other trademarks ...
http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cf...
|
T T h h e e J J o o u u r r n n e e y y o o f f ...
its launch in November 2003, CUBICIN has tracked as the most successful .... In 1999, Cubist filed a “Method of Administration” patent application based ...
http://www.cubist.com/downloads/Journey_of_CUBICIN.pdf...
|
Dockets Entered on October 23, 2007
2006E-0042, Patent Extension Application for CUBICIN (daptomycin for injection), U.S. Patent No. 4885243. CEP 1, U.S. Patent and Trademark Office to Cubist ...
http://www.fda.gov/ohrms/dockets/dailys/07/oct07/102307/1023...
|
Products & Pipeline - research on acute care drug candidates for ...
Cubist believes CUBICIN will continue growing (to greater than $750 Million ... thus enabling continued revenue growth beyond CUBICIN, which has patent ...
http://www.cubist.com/products/...
|
NDA-I1: NDA Approval Letter
US Patent Nos. 6468967; 5912226; 4885243; 4874843. 553. Cubicin is a trademark of Cubist Pharmaceuticals, Inc. 554. Manufactured for: ...
http://www.fda.gov/cder/foi/label/2003/21572_cubicin_lbl.pdf...
|
|
